ClinicalTrials.Veeva

Menu

The Canadian Follow-up Program for the ATTRACT Study (P04868)(TERMINATED)

Merck Sharp & Dohme (MSD) logo

Merck Sharp & Dohme (MSD)

Status

Terminated

Conditions

Arthritis, Rheumatoid

Treatments

Other: Retrospective Chart Review and Data collection

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

This is a Phase 4, retrospective chart review of subjects that participated in the ATTRACT study. Site investigators will conduct a chart review and complete a data collection form. The purpose of this study is to describe the treatment used and clinical outcomes of these subjects following completion of the ATTRACT trial up until their most recent assessment by the treating physicians.

Full description

Subjects were selected for this study using a non-probability sampling method.

Enrollment

13 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients must have been enrolled in the two year follow-up phase of ATTRACT and have continued treatment with the site investigator
  • Signature of informed consent.

Exclusion criteria

  • Not specified in the protocol.

Trial design

13 participants in 1 patient group

Cohort 1
Description:
Subjects previously enrolled in the ATTRACT trial from three Canadian sites.
Treatment:
Other: Retrospective Chart Review and Data collection

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems